Fixed Combinations of Glaucoma Medications.

@article{Babi2015FixedCO,
  title={Fixed Combinations of Glaucoma Medications.},
  author={Nikola M. Babi{\'c}},
  journal={Srpski arhiv za celokupno lekarstvo},
  year={2015},
  volume={143 9-10},
  pages={
          626-31
        }
}
The first line treatment in the management of glaucoma is topical medical therapy. Many patients with glaucoma require multiple medications for adequate intraocular pressure control. For patients who need multi-dose regimens to control intraocular pressure, fixed combinations offer convenience, efficacy and safety. This review summarizes the role, efficacy, mechanism of action and indications for use of modern fixed combination of topical glaucoma medications.The review shows the advantages and… CONTINUE READING

Similar Papers

Tables and Topics from this paper.

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 57 REFERENCES

Initial reduction of intraocular pressure with dorzolamide and timolol fixed combination in open-angle glaucoma and ocular hypertension

M Radaković, V Čanadanović, N Babić, N. Naumović
  • Medicina danas
  • 2011
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Comparison of the efficacy and safety of travoprost and timolol throughout diurnal curve

N Babić, V Čanadanović, Z. Žikić
  • Asian Journal of Ophthalmology
  • 2008
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Travoprost Study Group. Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure

RL Fellman, KE Sullivan, +3 authors DF Turner
  • Ophthalmology
  • 2002
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

International Travoprost Study Group. Comparison of topical travoprost drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension

I Goldberg, J Cuhna-Vaz, +3 authors KE Sullivan
  • J Glaucoma
  • 2001
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%.

  • Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • 2013
VIEW 1 EXCERPT